These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3002995)

  • 1. DNA flow cytometry of ovarian tumors with correlation to histopathology.
    Feichter GE; Kühn W; Czernobilsky B; Müller A; Heep J; Abel U; Haag D; Kaufmann M; Rummel HH; Kubli F
    Int J Gynecol Pathol; 1985; 4(4):336-45. PubMed ID: 3002995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
    Christov K; Vassilev N
    Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
    Lage JM; Weinberg DS; Huettner PC; Mark SD
    Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric analysis of DNA ploidy using paraffin-embedded germ cell tumors].
    Yoshihiro S; Yamamoto M; Shimabukuro T; Matsuyama H; Yamamoto N; Sakatoku J
    Hinyokika Kiyo; 1991 Jun; 37(6):601-5. PubMed ID: 1892008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-phase fractions and DNA-ploidy of oropharyngeal squamous epithelium carcinomas compared with histologic grade, stage, response to chemotherapy and survival.
    Feichter GE; Maier H; Adler D; Born IA; Abel U; Haag D; Goerttler K
    Acta Otolaryngol; 1987; 104(3-4):377-84. PubMed ID: 3673566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer.
    Feichter GE; Mueller A; Kaufmann M; Haag D; Born IA; Abel U; Klinga K; Kubli F; Goerttler K
    Int J Cancer; 1988 Jun; 41(6):823-8. PubMed ID: 3372059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxyribonucleic acid analysis by flow cytometry of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potential.
    Peters WA; Howard DR; Andersen WA; Figge DC
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1646-53; discussion 1653-4. PubMed ID: 1615971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
    Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
    Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content of ovarian immature teratomas and malignant germ cell tumors.
    Baker BA; Frickey L; Yu IT; Hawkins EP; Cushing B; Perlman EJ
    Gynecol Oncol; 1998 Oct; 71(1):14-8. PubMed ID: 9784313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
    Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
    Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
    Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
    Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ploidy of ovarian dysgerminomas: correlation with clinical outcome.
    Palmquist MB; Webb MJ; Lieber MM; Gaffey TA; Nativ O
    Gynecol Oncol; 1992 Jan; 44(1):13-6. PubMed ID: 1730420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy analysis of pediatric germ cell tumors.
    Silver SA; Wiley JM; Perlman EJ
    Mod Pathol; 1994 Dec; 7(9):951-6. PubMed ID: 7892165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.